Targeted Cancer Drug Delivery System Enters Phase III Trial

A new targeted drug-delivery system called TAMP aims to deliver chemotherapy directly near pancreatic tumors rather than throughout the entire body. This technology is currently advancing into a Phase III trial to test its efficacy and safety in treating aggressive cancers. The development represents a significant shift toward precision medicine that could drastically reduce systemic side effects for patients.